ISL
OSTX

Ingalls & Snyder LLC’s OS Therapies Inc OSTX Stock Holding History

Ingalls & Snyder LLC’s Portfolio OSTX Stock Details OSTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$52K Hold
36,676
– – ﹤0.01% 463
2025
Q4 		$51K Hold
36,676
– – ﹤0.01% 462
2025
Q3 		$72K Hold
36,676
– – ﹤0.01% 473
2025
Q2 		$69K Hold
36,676
– – ﹤0.01% 452
2025
Q1 		$56K Buy
+36,676
New +$86K ﹤0.01% 438

Other funds holding OSTX

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
HFS
Howard Financial Services Dallas, Texas $1B AUM 20.02% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Ingalls & Snyder LLC's OSTX Position: Q1 2026 in Review

Ingalls & Snyder LLC held its OS Therapies Inc (OSTX) position steady in Q1 2026 at 36,676 shares worth $52K. The position accounts for ﹤0.01% of the portfolio, ranked #463.

Ingalls & Snyder LLC first reported a position in OSTX in Q1 2025 and has held it in 5 quarters since. The position peaked at $72K in Q3 2025. 29 funds tracked by Wall St. Rank hold OSTX as of Q1 2026.

  • Ingalls & Snyder LLC held 36,676 shares of OS Therapies Inc worth $52K as of Q1 2026.
  • Ingalls & Snyder LLC left its OS Therapies Inc share count unchanged in Q1 2026.
  • OS Therapies Inc made up ﹤0.01% of Ingalls & Snyder LLC's portfolio in Q1 2026, its #463 holding.
  • Ingalls & Snyder LLC first reported a position in OS Therapies Inc in Q1 2025 and has held it in 5 quarters since.
  • Ingalls & Snyder LLC's OS Therapies Inc position peaked at $72K in Q3 2025.
  • 29 funds tracked by Wall St. Rank held OS Therapies Inc as of Q1 2026.

Based on Ingalls & Snyder LLC's 13F filing for Q1 2026, filed 13 May 2026.